BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18162535)

  • 1. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer.
    Rauch TA; Zhong X; Wu X; Wang M; Kernstine KH; Wang Z; Riggs AD; Pfeifer GP
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):252-7. PubMed ID: 18162535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation biomarkers for lung cancer.
    Rauch TA; Wang Z; Wu X; Kernstine KH; Riggs AD; Pfeifer GP
    Tumour Biol; 2012 Apr; 33(2):287-96. PubMed ID: 22143938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay.
    Rauch T; Wang Z; Zhang X; Zhong X; Wu X; Lau SK; Kernstine KH; Riggs AD; Pfeifer GP
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5527-32. PubMed ID: 17369352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation patterns in lung carcinomas.
    Pfeifer GP; Rauch TA
    Semin Cancer Biol; 2009 Jun; 19(3):181-7. PubMed ID: 19429482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis.
    Takai D; Yagi Y; Wakazono K; Ohishi N; Morita Y; Sugimura T; Ushijima T
    Oncogene; 2001 Nov; 20(51):7505-13. PubMed ID: 11709722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.
    Heller G; Babinsky VN; Ziegler B; Weinzierl M; Noll C; Altenberger C; Müllauer L; Dekan G; Grin Y; Lang G; End-Pfützenreuter A; Steiner I; Zehetmayer S; Döme B; Arns BM; Fong KM; Wright CM; Yang IA; Klepetko W; Posch M; Zielinski CC; Zöchbauer-Müller S
    Carcinogenesis; 2013 Mar; 34(3):513-21. PubMed ID: 23172663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis.
    Park J; Brena RM; Gruidl M; Zhou J; Huang T; Plass C; Tockman MS
    Cancer Biomark; 2005; 1(2-3):193-200. PubMed ID: 17192040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
    Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.
    Grageda M; Silveyra P; Thomas NJ; DiAngelo SL; Floros J
    Exp Lung Res; 2015 Mar; 41(2):93-102. PubMed ID: 25514367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 CpG islands methylation in human lung cancer: a pilot study.
    Bruno P; Gentile G; Mancini R; De Vitis C; Esposito MC; Scozzi D; Mastrangelo M; Ricci A; Mohsen I; Ciliberto G; Simmaco M; Mariotta S
    Biochem Biophys Res Commun; 2012 Sep; 426(3):306-9. PubMed ID: 22925896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchical clustering of lung cancer cell lines using DNA methylation markers.
    Virmani AK; Tsou JA; Siegmund KD; Shen LY; Long TI; Laird PW; Gazdar AF; Laird-Offringa IA
    Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):291-7. PubMed ID: 11895880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.
    Yegnasubramanian S; Haffner MC; Zhang Y; Gurel B; Cornish TC; Wu Z; Irizarry RA; Morgan J; Hicks J; DeWeese TL; Isaacs WB; Bova GS; De Marzo AM; Nelson WG
    Cancer Res; 2008 Nov; 68(21):8954-67. PubMed ID: 18974140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of tissue-specific differentially methylated genes with differential gene expression in non-small cell lung cancer].
    Yin LG; Zou ZQ; Zhao HY; Zhang CL; Shen JG; Qi L; Qi M; Xue ZQ
    Mol Biol (Mosk); 2014; 48(5):797-804. PubMed ID: 25842865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer.
    Nishiyama R; Qi L; Lacey M; Ehrlich M
    Mol Cancer Res; 2005 Nov; 3(11):617-26. PubMed ID: 16317087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
    Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K
    Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomethylation of Alu repetitive elements in esophageal mucosa, and its potential contribution to the epigenetic field for cancerization.
    Matsuda Y; Yamashita S; Lee YC; Niwa T; Yoshida T; Gyobu K; Igaki H; Kushima R; Lee S; Wu MS; Osugi H; Suehiro S; Ushijima T
    Cancer Causes Control; 2012 Jun; 23(6):865-73. PubMed ID: 22527164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.